Comment: impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections

Antonio J Mateu-de; M Marin-Casino; Santiago Grau Cerrato

Comment: impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections

Antonio J Mateu-de, M Marin-Casino, Santiago Grau Cerrato

Department of Pharmacology, Therapeutics and Toxicology

Research output: Contribution to journal › Article › Research

Original language	English
Pages (from-to)	2280-2281
Journal	Annals of Pharmacotherapy
Volume	40
Issue number	12
Publication status	Published - 1 Jan 2006

Cite this

@article{1eb78003a3e147bcacd4fe332619bab4,

title = "Comment: impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections",

author = "Mateu-de, {Antonio J} and M Marin-Casino and {Grau Cerrato}, Santiago",

year = "2006",

month = jan,

day = "1",

language = "English",

volume = "40",

pages = "2280--2281",

number = "12",

}

Comment: impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections. / Mateu-de, Antonio J; Marin-Casino, M; Grau Cerrato, Santiago.

In: Annals of Pharmacotherapy, Vol. 40, No. 12, 01.01.2006, p. 2280-2281.

Research output: Contribution to journal › Article › Research